Molecular Cancer · 2010 · 49 citations · 25 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyTumor ProgressionAngiogenesisAngiogenesis In CancerHepatobiliary CancerHepatocellular CarcinomaLiver CancerTumor Growth KineticsAngiogenic ResponseHepatocellular Carcinoma PathogenesisIntraperitoneal AdministrationOrthotopic Tumor ModelsRodent Tumor ModelsTumor Angiogenesis Models
BACKGROUND: The increasing incidence of hepatocellular carcinoma in Western countries has led to an expanding interest of scientific research in this field. Therefore, a vast need of experimental models that mimic the natural pathogenesis of hepatocellular carcinoma (HCC) in a short time period is present. The goal of our study was (1) to develop an efficient mouse model for HCC research, in which tumours develop in a natural background of fibrosis and (2) to assess the time-dependent angiogenic changes in the pathogenesis of HCC. METHODS: Weekly intraperitoneal injections with the hepatocarcinogenic compound N-nitrosodiethylamine was applied as induction method and samples were taken at several time points to assess the angiogenic changes during the progression of HCC. RESULTS: The N-nitrosodiethylamine-induced mouse model provides well vascularised orthotopic tumours after 25 weeks. It is a representative model for human HCC and can serve as an excellent platform for the development of new therapeutic targets.
25
Peter Carmeliet, Lieve Moons, Aernout Luttun et al. · Nature Medicine · 2001 · 1.7K citations
Mouse xenograft models vs GEM models for human cancer therapeutics
Ann Richmond, Yingjun Su · Disease Models & Mechanisms · 2008 · 469 citations · Full text
Medicine, Cancer Biology, Oncology +12
Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
Timothy R. DeGrado, S. W. BALDWIN, S Wang et al. · PubMed · 2001 · 334 citations
Medicine, Oncology, Pharmacology +14